Anti-SFRP2 Antibody

(No reviews yet) Write a Review
SKU:
STPA00085
Antibody Type:
Polyclonal
Applications:
WB
Applications:
IHC
Reactivity:
Human
Reactivity:
Mouse
Host Species:
Rabbit
  • Immunohistochemistry analysis using Rabbit Anti-SFRP2 Polyclonal Antibody (STPA00085). Tissue: Liver. Species: Human. Fixation: Formalin Fixed Paraffin-Embedded. Primary Antibody: Rabbit Anti-SFRP2 Polyclonal Antibody (STPA00085) at 1:50 for 30 min at RT. Counterstain: Hematoxylin. Magnification: 20X. HRP-DAB Detection.
  • Western blot analysis of Mouse Brain showing detection of 33.5 kDa SFRP2 protein using Rabbit Anti-SFRP2 Polyclonal Antibody (STPA00085). Load: 15 µg. Block: 5% Skim Milk powder in TBST. Primary Antibody: Rabbit Anti-SFRP2 Polyclonal Antibody (STPA00085) at 1:1000 for 2 hours at RT with shaking. Secondary Antibody: Goat Anti-Rabbit IgG: HRP at 1:5000 for 1 hour at RT. Color Development: ECL solution for 5 min at RT.
Frequently bought together:

Description

SFRP2 Antibody

SFRP2 Antibody is a rabbit polyclonal antibody directed against SFRP2, offered by Assay Genie for research applications. Reported applications include WB and IHC. Reported reactivity: Human and Mouse. Purified by Peptide Affinity.

Secreted frizzled-related protein 2 (SFRP2) is a member of the SFRP family that modulates Wnt signaling—a pathway essential for neurodevelopment, synaptic plasticity, and tissue regeneration. While SFRP2 has been extensively studied in skeletal stem cell biology, emerging evidence suggests its relevance in the central nervous system, particularly in neurodegenerative disease contexts (1). SFRP2 can act as both a Wnt antagonist and agonist, depending on cellular context. In neural tissues, Wnt signaling governs processes such as neuronal differentiation, axonal guidance, and synaptic maintenance. Dysregulation of Wnt pathways has been implicated in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. SFRP2’s ability to fine-tune Wnt activity positions it as a potential regulator of neuroinflammation and neurogenesis. Recent studies show that SFRP2 deficiency impairs stem cell recruitment and differentiation, suggesting that it may influence neural stem cell function and brain repair mechanisms (1). Its role in modulating LRP6 activation and downstream Wnt target genes such as Axin2 and Cyclin D1 further supports its involvement in maintaining cellular homeostasis under stress or injury. Given its dual regulatory capacity and influence on regenerative signaling, SFRP2 is a promising candidate for therapeutic exploration in neurodegenerative disease. Enhancing SFRP2 activity may promote neural resilience and repair, offering new avenues for intervention in aging and neurodegeneration. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose